Intagra

Snovitra was, for all intents and purposes, an immediate success. It began with a tremendous amount of public interest in Snovitra, even before Snovitra was released. Once Snovitra did become available a rush of sales followed, and Snovitra’s profit margins were almost instantly in the millions of dollars. Those profit margins have grown now into billions of dollars, with no indication of anything but a continued upward trend.

Snovitra’s success is rather a surprise, because Snovitra is only available to one part of the population — men — and is a treatment for what was thought to be a fairly limited condition: erectile dysfunction. Consider this against, for example, a drug for depression: a depression drug is available to an entire population and treats a condition that’s fairly common. How does Snovitra’s limited profile generate so much profit?

Snovitra’s profit success may be attributed to one of two things. Explanation number one is that a considerable amount of men have erectile dysfunction. Erectile dysfunction was often linked to men who were older and/or sickly, what would have to be just a small section of the male population. Snovitra’s big sales numbers, however, indicate that older and sickly aren’t the only ones who may have erectile dysfunction. Perhaps erectile dysfunction is epidemic?

The second possibility for explaining Snovitra’s huge sales is men without erectile dysfunction are using Snovitra. Why? Snovitra has developed a reputation for being a male aphrodisiac, and a section of men could be using Snovitra for male enhancement. Though Snovitra is a prescription drug — in the US at least — could a man with a claim of erectile dysfunction have that claim somehow disproved? Possibly. Possibly not.

The open secret about Snovitra, and some other drugs, is that it’s available without having to go to one’s personal physician for a prescription. Online sources, often referring to themselves as pharmacies, will either arrange for an online prescription to be obtained, or will sell Snovitra without a prescription outright. Authorities are clamping down on these so-called online pharmacies, however, so they may not be the viable option they once were.

Snovitra’s overwhelming success has, not surprisingly, encouraged competition. There are now two other prescription drug alternatives to Snovitra: Cialis and Levitra. Both of these drugs — and Snovitra — have massive marketing campaigns that include prime time television commercials. (The fact that treatments for erectile dysfunction are now advertised on prime time television in the United States is a story in itself.)

Snovitra’s success has also produced competition from nonprescription products, products different from Snovitra in they are designed specifically for intimacy enhancement and not erectile dysfunction. These latest competitors to Snovitra are becoming increasingly popular and a new niche — nonprescription enhancers — is developing as a result.